Hepatitis C News and Research

Latest Hepatitis C News and Research

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

A new study by scientists from the Vrije Universiteit Brussel calls for a new gold standard in research to treat non-alcoholic steatohepatitis, an obesity-linked chronic liver disease impacting millions of people of all ages worldwide, which can progress to liver cancer if untreated, creating a massive strain on an already overburdened healthcare system.

18 Jul 2018

New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions

A new machine learning framework, dubbed ExPecto, can predict the effects of genetic mutations in the so-called "dark matter" regions of the human genome.

17 Jul 2018

Routine screening, treatment could help stem nationwide opioid epidemic

To help stem the nationwide opioid epidemic and related increases in HIV, hepatitis C and other infections, health care providers should routinely screen and treat patients for opioid abuse when they come to clinics and hospitals seeking other services.

16 Jul 2018

High opioid doses, concurrent sedative use are key factors for overdose risk in Medicaid recipients

Among Medicaid recipients taking prescription opioids, high opioid doses and concurrent treatment with benzodiazepine sedatives are among the key, potentially modifiable risk factors for fatal overdose, reports a study in the August issue of Medical Care.

13 Jul 2018

Researchers find experimental compound to treat fibrotic diseases

Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases - kidney, liver and lung fibrosis -- the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.

13 Jul 2018

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.

12 Jul 2018

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.

9 Jul 2018

Researchers trace history of human Hepatitis B in the Bronze Age

Thanks to viral traces in the genomes of ancient people, researchers from South Ural State University were able to determine that man has been suffering from Hepatitis B since at least the Bronze Age.

9 Jul 2018

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

9 Jul 2018

Increase in marker of inflammation from mid to late life linked with dementia

Researchers at Johns Hopkins have added to evidence that rising and chronic inflammation as measured by a biomarker in the blood in middle and late age are linked to visible structural changes in the brains of people with poor cognition and dementia.

2 Jul 2018

Researchers develop inexpensive blood test to diagnose hepatitis B patients

A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions.

2 Jul 2018

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

It is currently recommended in Europe that screening for hepatitis C virus should target people at high risk of infection.

2 Jul 2018

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Infection with the hepatitis C virus is a contagious liver disease with symptoms that range from mild illness for a few weeks to serious, lifelong liver problems.

28 Jun 2018

Illicit drug supply at record heights

According to a 2018 World Drug report released by the United Nations Office on Drugs and Crime (UNODC) this week (26th June 2018) the supply of illicit drugs such as cocaine, opium and heroin have reached record heights.

28 Jun 2018

ABPI associated with NHS for 70 years in pharmaceutical research

In this special year, both the NHS and the Association of the British Pharmaceutical Industry are celebrating our respective 70th anniversaries. The histories of these two organizations have been inextricably linked since 1948 and our relationship with the NHS continues to go from strength to strength.

25 Jun 2018

Hepatitis C News and Research

Latest Hepatitis C News and Research

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions

Routine screening, treatment could help stem nationwide opioid epidemic

High opioid doses, concurrent sedative use are key factors for overdose risk in Medicaid recipients

Researchers find experimental compound to treat fibrotic diseases

Study: Hepatitis C vaccine could drastically reduce transmission among injecting drug users

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

Researchers trace history of human Hepatitis B in the Bronze Age

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

Increase in marker of inflammation from mid to late life linked with dementia

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Mathematical model assesses efficacy, cost-effectiveness of screening strategies for HCV

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Illicit drug supply at record heights

ABPI associated with NHS for 70 years in pharmaceutical research

Scientists discover secret to success of antiviral gene

If you’ve got hep C, spitting can be a felony

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

Researchers uncover racial differences in debilitating itchy skin condition

Video consultations boost survival rates of liver disease patients, study finds

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in